Drug Type Unknown |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Aviceda Therapeutics, Inc.Startup |
Active Organization Aviceda Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Fibrosis | Phase 1 | US | Aviceda Therapeutics, Inc.Startup | 26 Jan 2022 |